Skip to main content
profile image
Selected Works of Philip Mease, MD
Presentation
Ixekizumab Reduces Disease Activity in Active Psoriatic Arthritis Patients Who Had Previous Inadequate Response to Tumour Necrosis Factor-Inhibitors. German DGRh congress (Deutsche Gesellschaft für Rheumatologie), Mannheim, Germany, Sept 2018.
German DGRh congress (Deutsche Gesellschaft für Rheumatologie) (2018)
  • LC Coates
  • Philip Mease, Providence St. Joseph Health
  • M. Elaine Husni, Cleveland Clinic
Link
Disciplines
Publication Date
September, 2018
Location
Mannheim
Citation Information
LC Coates, Philip Mease and M. Elaine Husni. "Ixekizumab Reduces Disease Activity in Active Psoriatic Arthritis Patients Who Had Previous Inadequate Response to Tumour Necrosis Factor-Inhibitors. German DGRh congress (Deutsche Gesellschaft für Rheumatologie), Mannheim, Germany, Sept 2018." German DGRh congress (Deutsche Gesellschaft für Rheumatologie) (2018)
Available at: http://works.bepress.com/philip-mease/121/